Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors
Lucia Silvestrini, Norhan Belhaj, Lucia Comez, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 73

Showing 26-50 of 73 citing articles:

Molecular mechanisms of drug resistance and compensation in SARS-CoV-2 main protease: the interplay between E166 and L50
Sarah N. Zvornicanin, Ala M. Shaqra, Julia M. Flynn, et al.
mBio (2025)
Open Access
A SARS-CoV-2 Mpro mutation conferring ensitrelvir resistance paradoxically increases nirmatrelvir susceptibility
Min‐Suk Song, Seong Cheol Min, Jin-Ju Seo, et al.
Research Square (Research Square) (2025)
Closed Access
Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors
Nedra Mekni, Claudia Coronnello, Thierry Langer, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7714-7714
Open Access | Times Cited: 23
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
Bruno Rizzuti, Laura Ceballos-Laita, David Ortega-Alarcón, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 892-892
Open Access | Times Cited: 23
Deciphering the therapeutical potentials of rosmarinic acid
Sally El Kantar, Ali Yassin, Bilal Nehmeh, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Probing Ligand Binding Sites on Large Proteins by Nuclear Magnetic Resonance Spectroscopy of Genetically Encoded Non-Canonical Amino Acids
Kasuni B. Ekanayake, Mithun C. Mahawaththa, Haocheng Qianzhu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 5289-5304
Closed Access | Times Cited: 9
Harnessing Brazilian biodiversity database: identification of flavonoids as potential inhibitors of SARS-CoV-2 main protease using computational approaches and all-atom molecular dynamics simulation
João Augusto Pereira da Rocha, Renato Araújo da Costa, Andréia do Socorro Silva da Costa, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 3
SARS-CoV-2 Mpro responds to oxidation by forming disulfide and NOS/SONOS bonds
P. Reinke, Robin Schubert, Dominik Oberthür, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Revealing the impact of active site residues in modeling the inhibition mechanism of SARS-Cov-2 main protease by GC373
Mohamed M. Aboelnga, Maya Petgrave, Subha Kalyaanamoorthy, et al.
Computers in Biology and Medicine (2025) Vol. 187, pp. 109779-109779
Closed Access
SARS‐CoV‐2 Mpro Dihedral Angles Reveal Allosteric Signaling
Daniel J. Evans, Samreen Sheraz, Albert Y. Lau
Proteins Structure Function and Bioinformatics (2025)
Closed Access
In silico evidence of beauvericin antiviral activity against SARS-CoV-2
Charbel Al Khoury, Zainab Bashir, Sima Tokajian, et al.
Computers in Biology and Medicine (2021) Vol. 141, pp. 105171-105171
Open Access | Times Cited: 20
Phytochemicals in Drug Discovery - A Confluence of Tradition and Innovation
Patience Chihomvu, A. Ganesan, Simon Gibbons, et al.
(2024)
Open Access | Times Cited: 2
Effects of Monovalent Salt on Protein-Protein Interactions of Dilute and Concentrated Monoclonal Antibody Formulations
Amy Y. Xu, Nicholas Clark, Joseph Pollastrini, et al.
Antibodies (2022) Vol. 11, Iss. 2, pp. 24-24
Open Access | Times Cited: 11
The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication
Elisa Bianconi, Anna Gidari, Maria Souma, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 6
Unexpected Single-Ligand Occupancy and Negative Cooperativity in the SARS-CoV-2 Main Protease
Simone Albani, Elisa Costanzi, Gia Linh Hoang, et al.
Journal of Chemical Information and Modeling (2023) Vol. 64, Iss. 3, pp. 892-904
Open Access | Times Cited: 6
On Inactivation of the Coronavirus Main Protease
Hong Ha Nguyen, Jim Tufts, David D. L. Minh
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 5, pp. 1644-1656
Closed Access | Times Cited: 2
Characterization of alternate encounter assemblies of SARS-CoV-2 main protease
Annie Aniana, Nashaat T. Nashed, Rodolfo Ghirlando, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 9, pp. 107675-107675
Open Access | Times Cited: 2
Ligand-based discovery of coronavirus main protease inhibitors using MACAW molecular embeddings
Jie Dong, Mihayl Varbanov, Stéphanie Philippot, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 24-35
Open Access | Times Cited: 10
Unveiling the Effect of Low pH on the SARS-CoV-2 Main Protease by Molecular Dynamics Simulations
Haruna Luz Barazorda-Ccahuana, Miroslava Nedyalkova, Francesc Mas, et al.
Polymers (2021) Vol. 13, Iss. 21, pp. 3823-3823
Open Access | Times Cited: 13
Maturation of the SARS-CoV-2 virus is regulated by dimerization of its main protease
Shreyas Kaptan, Mykhailo Girych, Giray Enkavi, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 3336-3346
Open Access | Times Cited: 9
A review on molecular docking analysis of phytocompounds against SARS-CoV-2 druggable targets
Abdullahi Temitope Jamiu, Carolina H. Pohl, Sharafa A Bello, et al.
All Life (2021) Vol. 14, Iss. 1, pp. 1100-1128
Open Access | Times Cited: 11
Surface cysteines could protect the SARS-CoV-2 main protease from oxidative damage
Raheleh Ravanfar, Yuling Sheng, Mona Shahgholi, et al.
Journal of Inorganic Biochemistry (2022) Vol. 234, pp. 111886-111886
Open Access | Times Cited: 7
A Critical Study on Acylating and Covalent Reversible Fragment Inhibitors of SARS‐CoV‐2 Main Protease Targeting the S1 Site with Pyridine
Rebekka Wamser, Szymon Pach, Christoph Arkona, et al.
ChemMedChem (2023) Vol. 18, Iss. 9
Open Access | Times Cited: 4
The Discovery of Novel Small Oxindole‐Based Inhibitors Targeting the SARS‐CoV‐2 Main Protease (Mpro)
Lara Alzyoud, Radwa E. Mahgoub, Feda E. Mohamed, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 11
Open Access | Times Cited: 4
Dimeric and monomeric conformation of SARS-CoV-2 main protease: New technical approaches based on IR radiation
Federica Piccirilli, Hendrik Vondracek, Lucia Silvestrini, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2024) Vol. 322, pp. 124772-124772
Open Access | Times Cited: 1

Scroll to top